Aibotics Inc. (AIBT)
OTCMKTS · Delayed Price · Currency is USD
0.0007
0.00 (0.00%)
Mar 26, 2026, 1:03 PM EST
Aibotics Market Cap
Aibotics has a market cap or net worth of $377.56 thousand as of March 26, 2026. Its market cap has decreased by -31.50% in one year.
Market Cap
377.56K
Enterprise Value
1.63M
Revenue
2.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 21, 2021, Aibotics's market cap has decreased from 42.01M to 377.56K, a decrease of -99.10%. That is a compound annual growth rate of -59.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 377.56K | -68.98% |
| Dec 31, 2025 | 1.22M | 1,088.20% |
| Dec 30, 2024 | 102.44K | -57.02% |
| Dec 29, 2023 | 238.35K | -91.06% |
| Dec 30, 2022 | 2.67M | -91.49% |
| Dec 30, 2021 | 31.32M | -25.44% |
| Jan 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eloxx Pharmaceuticals | 715.14K |
| SQZ Biotechnologies Company | 707.79K |
| Hepion Pharmaceuticals | 697.22K |
| Lipella Pharmaceuticals | 693.13K |
| Bio-Path Holdings | 533.44K |
| Windtree Therapeutics | 449.88K |
| Innovation Pharmaceuticals | 423.01K |
| Actavia Life Sciences | 385.91K |